UBS Group AG - RXI PHARMACEUTICALS CORP NEW ownership

RXI PHARMACEUTICALS CORP NEW's ticker is RXIIW and the CUSIP is 74979C113. A total of 4 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q4 2016$1,0005,6000.00%
Other shareholders
RXI PHARMACEUTICALS CORP NEW shareholders Q1 2017
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 2,238,487$492,0000.03%
Hudson Bay Capital Management LP 781,317$172,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 2,222,222$489,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 30,000$7,0000.00%
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders